Mollichella Stephen M.
Transaction: 07/16/2026
OTHER
Change
+5,900
Price
Not reported
Filing
07/22/2026
Type
OTHER
Harmony Biosciences Holdings, Inc.
HRMY • Biotechnology
$0.00
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$2.21B
Growth
—
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 18.3%Positive revenue growth · 29.9%Positive free cash flow · 6.05Consistent free cash flow · 5/5Reasonable earnings multiple · 13.56
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:53 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Market Cap$2.21B
52W Range25.52 - 40.87
Beta0.94
Gross Margin77.16%
Oper. Margin24.00%
Profit Margin18.27%
Debt/Eq0.28
Current Ratio3.60
Quick Ratio3.58
Target$46.20
Price$0.00
Change0.00%
Market Cap$2.21B
52W Range25.52 - 40.87
Beta0.94
Gross Margin77.16%
Oper. Margin24.00%
Profit Margin18.27%
Debt/Eq0.28
Current Ratio3.60
Quick Ratio3.58
Target$46.20
Target Median$39.00
Target Range34.00 - 70.00
Volume1.21M
Avg Volume844.05K
EPS Surprise-0.21
Investment DNA
How strong this company looks for long-term investors
92
out of 100
Business Quality
Margins, moat, returns
89/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
87/100
Why this score▼
Stable or improving margins · 18.3%Positive revenue growth · 29.9%Positive free cash flow · 6.05Consistent free cash flow · 5/5Reasonable earnings multiple · 13.56Manageable debt level · 0.28
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$34.00
Mean
$46.20
Median
$39.00
High
$70.00
Insider Transactions
Recent executive and insider activity
Mollichella Stephen M.
Transaction: 07/16/2026
OTHER
Change
+20,750
Price
$36.76
Filing
07/22/2026
Type
OTHER
Mollichella Stephen M.
Transaction: 07/16/2026
OTHER
Change
0
Price
Not reported
Filing
07/22/2026
Type
OTHER
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mollichella Stephen M. | OTHER | +5,900 | Not reported | 07/16/2026 | 07/22/2026 |
| Mollichella Stephen M. | OTHER | +20,750 | $36.76 | 07/16/2026 | 07/22/2026 |
| Mollichella Stephen M. | OTHER | 0 | Not reported | 07/16/2026 | 07/22/2026 |
| Sender Gary | BUY | +21,872 | $30.76 | 05/14/2026 | 05/18/2026 |
| Sabater Juan A. | BUY | +21,872 | $30.76 | 05/14/2026 | 05/18/2026 |
| Graf R. Mark | BUY | +21,872 | $30.76 | 05/14/2026 | 05/18/2026 |
| Philip Ron M | BUY | +21,872 | $30.76 | 05/14/2026 | 05/18/2026 |
| Szyper Linda M | BUY | +21,872 | $30.76 | 05/14/2026 | 05/18/2026 |
| Germano Geno J | OTHER | 0 | Not reported | 05/14/2026 | 05/18/2026 |
| Germano Geno J | BUY | +21,231 | $30.76 | 05/14/2026 | 05/18/2026 |
| Budur Kumar | SELL | -8,882 | $31.83 | 05/01/2026 | 05/18/2026 |
| Budur Kumar | SELL | -18,750 | Not reported | 05/01/2026 | 05/18/2026 |
| Reicin Glenn | OTHER | 0 | Not reported | 04/14/2026 | 05/18/2026 |
| Reicin Glenn | BUY | +164,309 | $29.29 | 04/14/2026 | 05/18/2026 |
| Zaeske Adam H. | SELL | -3,173 | $27.62 | 04/07/2026 | 04/09/2026 |
| Zaeske Adam H. | SELL | -7,500 | Not reported | 04/07/2026 | 04/09/2026 |
| Ignelzi Troy A. | OTHER | 0 | Not reported | 04/02/2026 | 04/06/2026 |
| Ignelzi Troy A. | BUY | +17,710 | $27.74 | 04/02/2026 | 04/06/2026 |
| Anastasiou Peter | BUY | +212,241 | $27.74 | 04/02/2026 | 04/06/2026 |
| Kapadia Sandip | SELL | -3,746 | $37.15 | 01/26/2026 | 01/28/2026 |